Renal dysfunction and cardiovascular risk in rheumatic arthritis patients
- Authors: Rebrov A.P.1, Tyapkina M.A1, Karpova O.G1
-
Affiliations:
- Federal State Budgetary Educational Institution of Higher Professional Education V.I. Razumovskii Saratov state medical university of the Ministry of Healthcare of the Russian Federation
- Issue: No 4 (2018)
- Pages: 51-56
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/279392
- ID: 279392
Cite item
Open Access
Access granted
Abstract
Objectives. To examine of the renal dysfunction in patients with rheumatoid arthritis (RA), to identify the relationship of these indicators with risk factors for cardiovascular disease (CVD). Material and methods. The study included 73 patients with RA at the age 18 to 60 years without an associated renal diseases. We investigated the urinary excretions of a1-microglobulin (a1-Mg), albumin (Al), enzymes and glomerular filtration rate. Results. The urinary excretion of a1-Mg, Al and enzymes in patients with RA was higher than in healthy individuals. The most early marker of renal dysfunction was a1-Mg. The concentration of a1-Mg in urine was higher than in controls even in patients with normal urinary albumin excretion. The markers of the renal dysfunction in patients with RA correlated with the features of the development of the RA and with risk factors for CVD. Conclusions. It is important to assess of the renal function for risk stratification of CVD in patients with RA.
Full Text
About the authors
Andrey P. Rebrov
Federal State Budgetary Educational Institution of Higher Professional Education V.I. Razumovskii Saratov state medical university of the Ministry of Healthcare of the Russian Federation
Email: andreyrebrov@yandex.ru
professor, MD, head of the Department of hospital therapy of general medicine faculty
M. A Tyapkina
Federal State Budgetary Educational Institution of Higher Professional Education V.I. Razumovskii Saratov state medical university of the Ministry of Healthcare of the Russian FederationPhD, assistant professor of hospital therapy Department of general medicine faculty
O. G Karpova
Federal State Budgetary Educational Institution of Higher Professional Education V.I. Razumovskii Saratov state medical university of the Ministry of Healthcare of the Russian Federation
Email: lelya18101985@mail.ru
PhD, professor assistant of hospital therapy Department of general medicine faculty
References
- Насонов Е.Л. Каратеев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: под ред. Е.Л. Насонова, В.А. Насоновой. Ревматология. Национальное руководство. М., 2008. С. 290-331.
- Ranganath V.K., Maranian P., Elashoff D.A., Woodworth T., Khanna D., Hahn T., Sarkisian C., Kremer J.M., Furst D.E., Paulus H.E. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatol. (Oxford) 2013; 52(10): 1809-17.
- Matsushita K., Ballew S.H., Coresh J. Cardiovascular risk prediction in people with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2016; 25(6): 518-23.
- Ребров А.П., Тяпкина М.А., Волошинова Е.В. Субклиническое поражение почек у пациентов с ревматоидным артритом. Леч. врач 2012; 4: 40-2.
- Nauta F.L., Boertien W.E., Bakker S.J., van Goor H., van Oeveren W., de Jong P.E., Bilo H., Gansevoort R.T. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care. 2011; 34(4): 975-81.
- Dickson L.E., Wagner M.C., Sandoval R.M., Molitoris B.A. The proximal tubule and albuminuria: really! J. Am. Soc. Nephrol. 2014; 25(3): 443-53.
- Park M., Hsu C.Y., Go A.S., Feldman H.I., Xie D., Zhang X., Mifflin T., Waikar S.S., Sabbisetti V.S., Bonventre J.V., Coresh J., Nelson R.G., Kimmel P.L., Kusek J.W., Rahman M., Schelling J.R., Vasan R.S., Liu K.D. Chronic Renal Insufficiency Cohort (CRIC) Study Investigators; CKD Biomarkers Consortium. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin. J. Am. Soc. Nephrol. 2017; 12(5): 761-71.
- Ребров А.П., Карпова О.Г., Гайдукова И.З. Тубулярная дисфункция и факторы кардиоваскулярного риска у больных псориатическим артритом. Современные проблемы науки и образования 2013; 4: 125.
- Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M., Schmieder R.E., Sirnes P.A., Sleight P., Viigimaa M., Waeber B., Zannad F. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013; 31(7): 1281-357.
- Catapano A.L., Graham I., De Backer G., Wiklund O., Chapman M.J., Drexel H., Hoes A.W., Jennings C.S., Landmesser U., Pedersen T.R., Reiner Z., Riccardi G., Taskinen M.R., Tokgozoglu L., Verschuren W.M.,Vlachopoulos C., Wood D.A., Zamorano J.L. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016; 253: 281-344.
- Inker L.A., Astor B.C., Fox C.H., Isakova T., Lash J.P., Peralta C.A., Kurella Tamura M., Feldman H.I. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney. Dis. 2014; 63(5): 713-35.
- Becetti K., Oeser A., Ormseth M.J., Solus J.F., Raggi P., Stein C.M., Chung C.P. Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness. J. Rheumatol. 2015; 42(4): 593-8.
Supplementary files
